On Wednesday, IGI Laboratories, Inc. (NYSEMKT:IG)’s shares declined -34.59% to $5.20.
IGI Laboratories, Inc. (IG) declared it has presented its second abbreviated new drug application (ANDA) to the U.S. Food and Drug Administration (FDA) of 2015, which brings the Company’s total number of ANDA submissions now pending at the FDA to twenty-four.
IGI Laboratories, Inc., a specialty generic pharmaceutical company, develops, manufactures, and markets topical formulations in the United States. It sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms under IGI label.
Lumber Liquidators Holdings Inc (NYSE:LL)’s shares dropped -19.93% to $26.76.
Lumber Liquidators Holdings Inc (LL) declared financial results for the first quarter ended March 31, 2015.
First Quarter Results
Net sales in the first quarter of 2015 were $260.0 million, an enhance of 5.6% from the first quarter of 2014 and a compound annual growth rate of 6.2% over the first quarter of 2013. Net sales in the month of March 2015 were $89.4 million, a decrease of 12.8% in comparison to March 2014. Net sales trends in March 2015 were significantly weaker than trends in January and February 2015, as net sales were negatively influenced by unfavorable allegations surrounding the product quality of the Company’s laminates sourced from China. The Company opened four new stores during the first quarter of 2015 and was operating 356 locations at March 31, 2015.
Lumber Liquidators Holdings, Inc., together with its auxiliaries, operates as a multi-channel specialty retailer of hardwood flooring, and hardwood flooring enhancements and accessories.
At the end of Wednesday’s trade, Novadaq Technologies Inc. (NASDAQ:NVDQ)‘s shares dipped -16.84% to $10.37.
Novadaq Technologies Inc. (NVDQ) declared financial results for its first quarter ended March 31, 2015. Unless otherwise indicated, all dollar amounts in this press release are expressed in United States (“U.S.”) dollars.
For the three months ended March 31, 2015, NOVADAQ stated revenues of $11.7 million, an enhance of 14% from $10.3 million in the first quarter of 2014. Product sales raised by $1.7 million, or 18%, primarily due to a 45% enhance in recurring revenue, partially offset by a 1% decrease in capital sales. Revenue recognized on SPY Elite kit sales raised by 34% as a result of the Company recognizing 100% of SPY Elite sales, offset by an approximate 16% decrease in the number of SPY Elite kits sold.
Novadaq Technologies Inc. develops, manufactures, and markets fluorescence imaging products and therapeutic devices for use by surgeons in the operating room and other clinical settings in the United States and internationally.
Wynn Resorts, Limited (NASDAQ:WYNN), ended its Wednesday’s trading session with -16.64% loss, and closed at $108.77.
Wynn Resorts, Limited (WYNN) reported financial results for the first quarter ended March 31, 2015.
Net revenues for the first quarter of 2015 were $1,092.2 million, compared to $1,513.6 million in the first quarter of 2014. The decline was the result of a 37.7% net revenue decrease from our Macau Operations, partially offset by a 1.6% increase in net revenues from our Las Vegas Operations. Adjusted property EBITDA (1) was $323.0 million for the first quarter of 2015, a 34.7% decrease from $494.6 million in the first quarter of 2014.
Wynn Resorts, Limited, together with its auxiliaries, develops, owns, and operates destination casino resorts. It operates in two segments, Macau Operations and Las Vegas Operations.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
